Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

105962

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	IVF
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to reduce variation in the price of IVF cycles between clinical commissioning groups.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	212894
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>For National Health Service funded in-vitro fertilisation treatment, it is for clinical commissioning groups to decide with which fertility clinics to contract and agree the price payable with the service provider.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 17:39:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

422666

	registered interest
	date	20/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take further steps to support Anthony Nolan's Destination Cure campaign.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	12658
	answer	answer is ministerial correction date of answer 28/10/2015 answer text <br /> <br /><p>Since 2011, the Department of Health has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><br /><p>The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor. The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan provides a timely contribution to this work.</p><br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/10/2015 17:09:26 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

433830

	registered interest
	date	01/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccine Damage Payment Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the Vaccine Damage Payment scheme.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	902566
	answer	answer is ministerial correction date of answer 07/12/2015 answer text <p>Policy responsibility for the Vaccine Damage Payment Scheme transferred to the Department of Health from the Department for Work and Pensions (DWP) in May 2014 although DWP continues to administer this scheme. The scheme was last revised in 2007 and no assessment of effectiveness has been made since that date.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/12/2015 13:53:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

458532

	registered interest
	date	08/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Lipoedema
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will implement a treatment pathway for people who suffer from lipoedema to allow such people to receive liposuction on the NHS.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	30284
	answer	answer is ministerial correction date of answer 15/03/2016 answer text <p>There are several different treatments available for the management of lipoedema such as compression therapy, exercise and massage. There is limited evidence on the efficacy of liposuction for the treatment of lipoedema, and it is not routinely available on the National Health Service.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/03/2016 11:19:17 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

175260

	registered interest
	date	22/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	York Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people presented at the A&E Department at York Hospital in each month of (a) 2014 and (b) the last 10 years.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	221798
	answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>The configuration of local health services is a matter for the local NHS. The Monkgate walk in service relocated to the emergency department at York Hospital in April 2012 as part of the development of an integrated urgent care centre staffed by multi-disciplinary team of medical and nursing staff to treat minor illness and injury. This followed a period of engagement with patients and the public and key stakeholders including the York Health Overview and Scrutiny Committee.</p><p> </p><p> </p><p> </p><p>Information on presentations at the accident and emergency department at York Hospital is not available in the format requested.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 221796 question first answered 02/02/2015 16:56:23 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

175261

	registered interest
	date	22/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS Direct
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people living in (a) York, (b) Yorkshire and Humber and (c) England sought advice from NHS Direct in each of its last five years of operation.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	221797
	answer	answer is ministerial correction date of answer 02/02/2015 answer text <p><strong> </strong></p><p> </p><p>This information is not held centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/02/2015 16:52:50 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

175271

	registered interest
	date	22/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS Walk-in Centres: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when and for what reason the NHS walk-in centre in Monkgate, York has closed; and how many people used that centre in its last year of operation.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	221796
	answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>The configuration of local health services is a matter for the local NHS. The Monkgate walk in service relocated to the emergency department at York Hospital in April 2012 as part of the development of an integrated urgent care centre staffed by multi-disciplinary team of medical and nursing staff to treat minor illness and injury. This followed a period of engagement with patients and the public and key stakeholders including the York Health Overview and Scrutiny Committee.</p><p> </p><p> </p><p> </p><p>Information on presentations at the accident and emergency department at York Hospital is not available in the format requested.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 221798 question first answered 02/02/2015 16:56:23 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227139

	registered interest
	date	12/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: North Yorkshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which services the Vale of York Clinical Commissioning Group (CCG) declined to fund, in some or all cases, or restricted access to, for patients in their area, which were funded without such restriction for patients living in other CCG areas in 2013 and in each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227380
	answer	answer is ministerial correction date of answer 19/03/2015 answer text <p>This information is not collected centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/03/2015 16:15:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227142

	registered interest
	date	12/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vale of York Clinical Commissioning Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much Vale of York Clinical Commissioning Group spent on managing provider contracts in 2013 and in each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227389
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>This information is not collected centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/03/2015 17:39:31 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227819

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Defibrillators: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the number of automated defibrillators there were in (a) York Central constituency and (b) City of York Council area in 2010 and each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227785
	answer	answer is ministerial correction date of answer 23/03/2015 answer text <p>This information is not collected centrally.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/03/2015 17:38:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227836

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Procurement
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much per resident on average was spent by NHS England on centrally-procured NHS services in each clinical commissioning group (CCG) area in England in each year since CCGs were created.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227815
	answer	answer is ministerial correction date of answer 24/03/2015 answer text <p>Established in April 2013, NHS England directly commissions a number of services including primary care, specialised services, offender health and services for members of the armed forces.</p><p> </p><p> </p><p> </p><p>Monies spent on services directly commissioned by NHS England is not broken down to per resident or clinical commissioning group level.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/03/2015 17:32:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227837

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	York Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average waiting time for treatment in the A&E department at York Hospital was in 2009-10 and each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227812
	answer	answer is ministerial correction date of answer 24/03/2015 answer text <p>The information is not available in the format requested.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/03/2015 15:52:41 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227859

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average waiting time was for cancer test results (a) at York Hospital and (b) in England in 2009-10 and each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227991
	answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>Information is collected on waiting times from referral to test, but not from test to test result and is published online at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/" target="_blank">http://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/</a></p><p> </p><p> </p><p> </p><p>The collection includes all waits for 15 key diagnostic tests and procedures, but it is not possible to identify which were for suspected cancer.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/03/2015 13:52:20 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

227860

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	York Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average waiting time was for elective inpatient or day-case treatment at York Hospital (a) overall and (b) in each speciality in 2009-10 and each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227992
	answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>The information is not available in the format requested. Information available at Trust level is included in the attached table for York Hospitals NHS Foundation Trust.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/03/2015 14:47:11 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Waiting times - 2009-10 to 2013-14.xlsx title Data of waiting times per speciality-York Hospital
	tabling member	385 label Biography information for Sir Hugh Bayley

227881

	registered interest
	date	17/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	York Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people presenting at the A&E department at York Hospital waited more than four hours from arrival to discharge, admission or transfer in 2009-10 and each subsequent year.
	tabling member constituency	York Central
	tabling member printed	Sir Hugh Bayley
	uin	227813
	answer	answer is ministerial correction date of answer 24/03/2015 answer text <p>The information is not available in the format requested.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/03/2015 15:54:47 answering member 3918 label Biography information for Jane Ellison
	tabling member	385 label Biography information for Sir Hugh Bayley

521586

	registered interest
	date	25/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what his policy is on conscientious objection for midwives asked to (a) advise on and (b) participate in abortions.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	38464
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>Section 4 of the Abortion Act provides that “no person shall be under any duty, whether by contract or by any statutory or other legal requirement, to participate in any treatment authorised by this Act to which he has a conscientious objection”. In 2014, the Supreme Court ruled that this is limited to those staff who actually take part in treatment administered in a hospital or other approved place and does not include ancillary, administrative and managerial tasks that might be associated with treatment.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/06/2016 11:03:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4471 label Biography information for Rachael Maskell

521595

	registered interest
	date	25/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he plans to review the current time limits for abortion.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	38524
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>The Abortion Act 1967 sets out that an abortion may be carried out after 24 weeks gestation only where:</p><p> </p><p>― the termination is necessary to prevent grave permanent injury to the physical or mental health of the pregnant woman Section 1(1)(b); or</p><p> </p><p>― the continuance of the pregnancy would involve risk to the life of the pregnant woman, greater than if the pregnancy were terminated Section 1(1)(c); or</p><p> </p><p>― there is a substantial risk that if the child were born it would suffer from such physical or mental abnormalities as to be seriously handicapped Section 1(1)(d).</p><p> </p><p>In England and Wales it is accepted Parliamentary practice that proposals for changes to the Abortion Act come from backbench members and that decisions are made on the basis of free votes. The Government has no plans to review this legislation.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 38469 question first answered 07/06/2016 11:03:41 answering member 3918 label Biography information for Jane Ellison
	tabling member	4471 label Biography information for Rachael Maskell

521596

	registered interest
	date	25/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what his policy is on the introduction of abortion up to birth.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	38469
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>The Abortion Act 1967 sets out that an abortion may be carried out after 24 weeks gestation only where:</p><p> </p><p>― the termination is necessary to prevent grave permanent injury to the physical or mental health of the pregnant woman Section 1(1)(b); or</p><p> </p><p>― the continuance of the pregnancy would involve risk to the life of the pregnant woman, greater than if the pregnancy were terminated Section 1(1)(c); or</p><p> </p><p>― there is a substantial risk that if the child were born it would suffer from such physical or mental abnormalities as to be seriously handicapped Section 1(1)(d).</p><p> </p><p>In England and Wales it is accepted Parliamentary practice that proposals for changes to the Abortion Act come from backbench members and that decisions are made on the basis of free votes. The Government has no plans to review this legislation.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 38524 question first answered 07/06/2016 11:03:41 answering member 3918 label Biography information for Jane Ellison
	tabling member	4471 label Biography information for Rachael Maskell

660119

	registered interest
	date	16/12/2016
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Flood Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, how many companies and unincorporated businesses have received tax relief on contributions to partnership funding for flood protection.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	57994
	answer	answer is ministerial correction date of answer 20/12/2016 answer text <p>It is not currently possible to provide an estimate of the number of companies and unincorporated businesses receiving tax relief on these contributions as this could only be provided at disproportionate cost. As the measure came into effect from 1 January 2015, HM Revenue and Customs does not currently hold the necessary information collated in a way that would be able to generate the requested estimates.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/12/2016 14:22:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	4471 label Biography information for Rachael Maskell

712548

	registered interest
	date	20/03/2017
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	VAT: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, how many businesses were registered for value added tax in the (a) City of York constituency and (b) York unitary authority area in each year since 2005.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	68517
	answer	answer is ministerial correction date of answer 24/03/2017 answer text <p>The Office for National Statistics publication “UK Business: Activity, Size and Location” gives the total number of businesses registered for VAT and/or PAYE at parliamentary constituency and local authority level from 2009 onwards. Prior to this, the Department for Business, Enterprise and Regulatory Reform published tables showing the number of businesses registered for VAT.</p><p> </p><p>The estimates for a) City of York/ York Central constituency and b) York unitary authority for each year from 2005 are shown in the tables attached.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/03/2017 12:03:21 answering member 3918 label Biography information for Jane Ellison attachment 1 file name e Office for National Statistics publication.docx title table for pq 68517
	tabling member	4471 label Biography information for Rachael Maskell

171811

	registered interest
	date	02/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chemotherapy: Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the quality and availability of practical and emotional support services for cancer patients receiving chemotherapy.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	219596
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>The 2014 Cancer Patient Experience Survey reported that 93% of cancer patients surveyed who were being treated with radiotherapy and or chemotherapy received emotional support.</p><p> </p><p> </p><p> </p><p>The survey also reported that the majority of cancer patients who took part in the survey said they received advice on practical matters such as availability of support groups (83%) and free prescriptions (78%). Just over half of patients surveyed reported receiving advice on financial help and benefits. NHS England recognises there may be opportunities for improvement in this area.</p><p> </p><p> </p><p> </p><p>Living With and Beyond Cancer, a new joint initiative between NHS England and Macmillan Cancer Care, is currently in development. Areas the initiative is planning to focus on include ensuring all cancer patients have access to holistic needs assessment, treatment summary, cancer care review and a patient education and support event – the ‘Recovery Package’.</p><p> </p><p><strong> </strong></p><p> </p><p>Cancer Patient Survey Trust level reports are published online at:</p><p> </p><p> </p><p> </p><p><a href="http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey" target="_blank">http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 219595 question first answered 09/01/2015 13:47:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

171826

	registered interest
	date	02/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that the trust-level reports of the National Cancer Patient Experience Survey are more readily accessible to patients and the public.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	219595
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>The 2014 Cancer Patient Experience Survey reported that 93% of cancer patients surveyed who were being treated with radiotherapy and or chemotherapy received emotional support.</p><p> </p><p> </p><p> </p><p>The survey also reported that the majority of cancer patients who took part in the survey said they received advice on practical matters such as availability of support groups (83%) and free prescriptions (78%). Just over half of patients surveyed reported receiving advice on financial help and benefits. NHS England recognises there may be opportunities for improvement in this area.</p><p> </p><p> </p><p> </p><p>Living With and Beyond Cancer, a new joint initiative between NHS England and Macmillan Cancer Care, is currently in development. Areas the initiative is planning to focus on include ensuring all cancer patients have access to holistic needs assessment, treatment summary, cancer care review and a patient education and support event – the ‘Recovery Package’.</p><p> </p><p><strong> </strong></p><p> </p><p>Cancer Patient Survey Trust level reports are published online at:</p><p> </p><p> </p><p> </p><p><a href="http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey" target="_blank">http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 219596 question first answered 09/01/2015 13:47:01 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

429391

	registered interest
	date	19/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the adequacy of the provision of services targeted at young people with dementia.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	16992
	answer	answer is ministerial correction date of answer 26/11/2015 answer text <br /><p>The Government is clear that all types of dementia remain a priority and will implement the Prime Minister’s Challenge on Dementia 2020 in full to make sure that dementia care, support, awareness and research are transformed by 2020. That is why on 21 February 2015, the 2020 Challenge was launched.</p><br /><p>Under the Prime Minister’s Challenge on Dementia 2020, we wish to encourage greater personalisation in the provision of post-diagnosis services including for younger people with dementia – this means building support around the individual with dementia, their carer and family and providing them with more choice, control and flexibility in the way they receive care and support – regardless of the setting in which they receive it.</p><br /><p>The Challenge recognises that local commissioners and providers need to continue to improve their understanding of the best ways to tailor post-diagnosis support services based on their local population's needs.</p><br /><p>It is therefore for clinical commissioning groups and local authorities, working together, to ensure that high quality, personalised services are delivered for people with dementia and their carers.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/11/2015 16:19:42 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

435875

	registered interest
	date	07/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of whether local provision through clinical commissioning groups and local authorities is ensuring that high-quality, personalised services are being delivered for young people with dementia and their carers.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	18906
	answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The Government is clear that all types of dementia remain a priority and will implement the Prime Minister’s Challenge on Dementia 2020 in full to make sure that dementia care, support, awareness and research are transformed by 2020. Under the Prime Minister’s Challenge on Dementia 2020, we want to see:</p><p>- Every person diagnosed with dementia having meaningful care following their diagnosis, which supports them and those around them, with meaningful care being in accordance with published National Institute for Health and Care Excellence Quality Standards.</p><p>- Information on what post-diagnosis services are available locally and how these can be accessed, through for example an annual ‘information prescription’.</p><p>- Access to relevant advice and support to help and advice on what happens after a diagnosis and the support available through the journey.</p><p>- Carers of people with dementia being made aware of and offered the opportunity for respite, education, training, emotional and psychological support so that they feel able to cope with their caring responsibilities and to have a life alongside caring.</p><p>Under the 2020 Challenge, we wish to encourage greater personalisation in the provision of post-diagnosis services – this means building support around the individual with dementia, their carer and their family.</p><br /><p>It is for clinical commissioning groups and local authorities, working together, to ensure that high quality, personalised services are delivered for people with dementia including younger people and their carers.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/12/2015 12:44:57 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

710928

	registered interest
	date	14/03/2017
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Corporation Tax
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, whether when considering rates of UK corporation tax it is his Department's policy to take into account the spillover effect that a reduction in the UK's rate of corporation tax would have on other countries.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	67995
	answer	answer is ministerial correction date of answer 22/03/2017 answer text <p>The Government is cutting the rate of corporation tax to 17% by 2020 to deliver a tax system that better supports growth and innovation. The Government has no current plans to conduct a spillover analysis.</p><p> </p><p>The Government is committed to a competitive and fair tax system, and has led international efforts to tackle tax evasion and avoidance while supporting developing countries to implement tax reforms.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/03/2017 14:09:07 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

710929

	registered interest
	date	14/03/2017
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Multinational Companies: Tax Avoidance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, what steps he has taken to deter UK-headquartered multinational companies from using tax havens to avoid paying tax in developing countries.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	67925
	answer	answer is ministerial correction date of answer 22/03/2017 answer text <p>The UK has been at the forefront of the OECD Base Erosion and Profit Shifting (BEPS) Project to address the issue of multinational companies shifting profits to low or no tax locations where there is little or no economic activity.</p><p> </p><p>We have been participating in the ‘Inclusive Framework on BEPS Implementation’, which brings together 94 developed countries and developing countries to implement the BEPS outcomes. Through the G20 we have commissioned toolkits to assist developing countries in implementation.</p><p> </p><p>We have also funded assistance to help developing country tax authorities tackle tax avoidance by multinational companies, such as supporting the OECD’s Tax Inspectors Without Borders initiative, which has raised over $260 million additional revenue for developing countries.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/03/2017 14:11:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	4316 label Biography information for Mike Kane

174999

	registered interest
	date	21/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to revise the impact assessment for the proposed introduction of standardised packaging of tobacco in response to the analysis of that impact assessment by the Regulatory Policy Committee; and what plans he has to commission research to support such a revision.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	221536
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>A final impact assessment, reflecting available evidence and the summary report of consultation responses will be published in due course.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 221538 question first answered 27/01/2015 13:11:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

175000

	registered interest
	date	21/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to commission or conduct research on the potential cost of compensation to the intellectual property sector for the proposed introduction of standardised packaging of tobacco.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	221537
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>The Government has carefully considered all issues relevant to the introduction of standardised packaging of tobacco products, including legal aspects.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/01/2015 14:45:45 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

175001

	registered interest
	date	21/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he plans to take in response to the request of the Regulatory Policy Committee that compensation be included as a transition cost in a revised impact assessment of the proposed introduction of standardised packaging.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	221538
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>A final impact assessment, reflecting available evidence and the summary report of consultation responses will be published in due course.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 221536 question first answered 27/01/2015 13:11:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

179159

	registered interest
	date	11/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to paragraph 132 of the judgment of the European Court of Justice in the case C-491/01 - British American Tobacco (Investments) and Imperial Tobacco, 10 December 2002, if he will ensure that legislative proposals he plans to bring forward on the standardised packaging of tobacco will meet the standard set down in that judgment for sufficient space to be provided on that packaging to affix other material, in particular concerning trademarks.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	224180
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>In coming to its decision to proceed with the Standardised Packaging of Tobacco Regulations, the Government has given careful consideration to all the legal issues, including the implications of relevant European case law.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/02/2015 15:25:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

179166

	registered interest
	date	11/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what consideration he gave to owners and other beneficiaries of intellectual property rights relating to tobacco products in deciding to bring forward legislative proposals for standardised packaging.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	224176
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>The Government has given careful consideration to all of the wider aspects that relate to standardised packaging of tobacco, including intellectual property rights. <br> <br> The Government has also published an impact assessment, assessing the costs and benefits of the policy. This can be found at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/consultations/standardised-packaging-of-tobacco-products-draft-regulations" target="_blank">https://www.gov.uk/government/consultations/standardised-packaging-of-tobacco-products-draft-regulations</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/02/2015 15:24:34 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

226013

	registered interest
	date	09/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hospitals: Admissions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many finished admission episodes were carried out between May 2010 and the latest period for which figures are available; and how many such procedures were carried out in the equivalent period in the previous Parliament.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	226848
	answer	answer is ministerial correction date of answer 12/03/2015 answer text <p>In the first four years of this Parliament, between 1 May 2010 and 31 March 2014, which is the latest period for which data is available, there were around 59 million finished admission episodes.</p><p> </p><p> </p><p> </p><p>During the first four years of the previous Parliament (between 1 May 2005 and 31 March 2009), there were around 52 million finished admission episodes.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/03/2015 14:23:25 answering member 3918 label Biography information for Jane Ellison
	tabling member	4074 label Biography information for Mark Garnier

114567

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to clarify the law on abortion for the purpose of gender selection; and if he will make a statement.
	tabling member constituency	Wycombe
	tabling member printed	Steve Baker
	uin	213561
	answer	answer is ministerial correction date of answer 17/11/2014 answer text <p>The Government has consistently stated that abortion on the grounds of gender alone is illegal and repeated this in new guidance entitled <em>Guidance in Relation to Requirements of the Abortion Act 1967 - for all those responsible for commissioning, providing and managing services provision</em> which was published on 23 May this year. All independent providers are required to adhere to this guidance as part of their licensing conditions. A copy of this guidance is attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/11/2014 16:49:21 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Abortion_Guidance_Document May 2014.pdf title Abortion Guidance May 2014
	tabling member	4064 label Biography information for Mr Steve Baker

348311

	registered interest
	date	03/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Urgent and Emergency Care Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of progress by the NHS on implementation of the Keogh Review of urgent and emergency care; and if he will make a statement.
	tabling member constituency	Wycombe
	tabling member printed	Steve Baker
	uin	953
	answer	answer is ministerial correction date of answer 11/06/2015 answer text <p>On 3 June 2015, NHS England invited expressions of interest from organisations and partnerships across England to become vanguard sites for new care models focusing on urgent and emergency care. These sites will test new approaches to delivering urgent care and aim to improve the coordination of services and reduce pressure on accident and emergency departments. It is expected that about five million people will be covered by the initial phase of the vanguard sites, which could be rolled out across England in the next couple of years.</p><p> </p><p> </p><p> </p><p>Across England as a whole, new urgent and emergency care networks are being developed. These will operate strategically, to improve the consistency and quality of urgent and emergency care by bringing together System Resilience Groups (SRGs) and other stakeholders to address challenges in the urgent and emergency care system that are difficult for single SRGs to address in isolation.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/06/2015 14:24:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	4064 label Biography information for Mr Steve Baker

631721

	registered interest
	date	08/11/2016
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Welfare Tax Credits
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, if he will take steps to accelerate the processing of tax credit change of circumstances notifications.
	tabling member constituency	Wycombe
	tabling member printed	Steve Baker
	uin	52294
	answer	answer is ministerial correction date of answer 18/11/2016 answer text <p>There are currently three ways to report a change of circumstance: telephone, paper form or digitally. HM Revenue and Customs (HMRC) has processed UK tax credit change of circumstances in an average of less than ten days during the current tax year and is meeting all internal targets for dealing with changes. HMRC keeps performance levels under constant review, including opportunities for further improvements in this area.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 18/11/2016 14:42:53 answering member 3918 label Biography information for Jane Ellison
	tabling member	4064 label Biography information for Mr Steve Baker

654781

	registered interest
	date	08/12/2016
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Customs: EU Law
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, how many additional staff have been allocated to assist with the implementation of the new EU Customs Code which was introduced on 1 May 2016.
	tabling member constituency	Wrexham
	tabling member printed	Ian C. Lucas
	uin	56725
	answer	answer is ministerial correction date of answer 13/12/2016 answer text <p>The transition period for full implementation of the Union Customs Code runs to the end of 2019. HM Revenue and Customs is carrying out this work without the need for additional resources as part of its business as usual activities.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 13/12/2016 15:36:03 answering member 3918 label Biography information for Jane Ellison
	tabling member	1470 label Biography information for Ian C. Lucas

654783

	registered interest
	date	08/12/2016
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Customs: EU Law
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, how many applications made pursuant to the implementation of the new EU Customs Code have been processed.
	tabling member constituency	Wrexham
	tabling member printed	Ian C. Lucas
	uin	56733
	answer	answer is ministerial correction date of answer 13/12/2016 answer text <p>The Union Customs Code (UCC) provides for a transition arrangement for re-authorising the customs facilitations for traders through to 2019. To date HM Revenue and Customs has processed 291 UCC Authorised Economic Operator applications which is the major trade facilitation measure within the UCC.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 13/12/2016 15:28:18 answering member 3918 label Biography information for Jane Ellison
	tabling member	1470 label Biography information for Ian C. Lucas

485687

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the potential (a) effectiveness and (b) value for money of providing pre-exposure prophylaxis for HIV.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	32412
	answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Pre-exposure Prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p>A wide range of stakeholders were included in the initial work by NHS England on PrEP including the Department of Health, PHE, the Medical Research Council, voluntary organisations and Genitourinary and HIV Clinicians. NHS England will be building on the work to date by making available up to £2 million over the next two years to run a number of early implementer sites. These will be undertaken in conjunction with PHE.</p><p>The data on new HIV diagnosis is available in table 1a in the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls</a></p><p>As part of the PROUD study, PHE has assessed how many men may be considered high risk but it is not possible to estimate how many would seek to access PrEP.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 32413 32414 32415 32416 question first answered 11/04/2016 16:57:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	117 label Biography information for Sir Peter Bottomley

485689

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that pre-exposure prophylaxis commissioning is targeted at people most at risk of HIV infection.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	32413
	answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Pre-exposure Prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p>A wide range of stakeholders were included in the initial work by NHS England on PrEP including the Department of Health, PHE, the Medical Research Council, voluntary organisations and Genitourinary and HIV Clinicians. NHS England will be building on the work to date by making available up to £2 million over the next two years to run a number of early implementer sites. These will be undertaken in conjunction with PHE.</p><p>The data on new HIV diagnosis is available in table 1a in the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls</a></p><p>As part of the PROUD study, PHE has assessed how many men may be considered high risk but it is not possible to estimate how many would seek to access PrEP.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 32412 32414 32415 32416 question first answered 11/04/2016 16:57:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	117 label Biography information for Sir Peter Bottomley

485691

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people were diagnosed with HIV in each of the last 10 years.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	32414
	answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Pre-exposure Prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p>A wide range of stakeholders were included in the initial work by NHS England on PrEP including the Department of Health, PHE, the Medical Research Council, voluntary organisations and Genitourinary and HIV Clinicians. NHS England will be building on the work to date by making available up to £2 million over the next two years to run a number of early implementer sites. These will be undertaken in conjunction with PHE.</p><p>The data on new HIV diagnosis is available in table 1a in the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls</a></p><p>As part of the PROUD study, PHE has assessed how many men may be considered high risk but it is not possible to estimate how many would seek to access PrEP.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 32412 32413 32415 32416 question first answered 11/04/2016 16:57:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	117 label Biography information for Sir Peter Bottomley

485692

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with whom NHS England's specialised commissioning service has consulted in the past 18 months in preparation for the planned public consultation on pre-exposure prophylaxis.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	32415
	answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Pre-exposure Prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p>A wide range of stakeholders were included in the initial work by NHS England on PrEP including the Department of Health, PHE, the Medical Research Council, voluntary organisations and Genitourinary and HIV Clinicians. NHS England will be building on the work to date by making available up to £2 million over the next two years to run a number of early implementer sites. These will be undertaken in conjunction with PHE.</p><p>The data on new HIV diagnosis is available in table 1a in the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls</a></p><p>As part of the PROUD study, PHE has assessed how many men may be considered high risk but it is not possible to estimate how many would seek to access PrEP.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 32412 32413 32414 32416 question first answered 11/04/2016 16:57:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	117 label Biography information for Sir Peter Bottomley

485693

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will estimate how many at-risk men in which areas will (a) not receive and (b) receive pre-exposure prophylaxis for HIV in each of the next five years.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	32416
	answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Pre-exposure Prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p>A wide range of stakeholders were included in the initial work by NHS England on PrEP including the Department of Health, PHE, the Medical Research Council, voluntary organisations and Genitourinary and HIV Clinicians. NHS England will be building on the work to date by making available up to £2 million over the next two years to run a number of early implementer sites. These will be undertaken in conjunction with PHE.</p><p>The data on new HIV diagnosis is available in table 1a in the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/469321/National_Tables20102015.xls</a></p><p>As part of the PROUD study, PHE has assessed how many men may be considered high risk but it is not possible to estimate how many would seek to access PrEP.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 32412 32413 32414 32415 question first answered 11/04/2016 16:57:49 answering member 3918 label Biography information for Jane Ellison
	tabling member	117 label Biography information for Sir Peter Bottomley

438032

	registered interest
	date	14/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia: Hospital Beds
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the (a) rates of admission to hospital, (b) total hospital bed-days per population and (c) rates of admission to hospital from a nursing home or residential care home for patients with a secondary diagnosis of dementia and aged over (i) 65 and (ii) 75 years of age for each clinical commissioning group in England were in each month of the last five years.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	20003
	answer	answer is ministerial correction date of answer 17/12/2015 answer text <p><strong></strong></p><p>Information on (a) the rates of admission to hospital, (b) the total hospital bed-days per population and (c) the rates of admission to hospital from a nursing home or residential care home for patients with a secondary diagnosis of dementia who are aged (i) over 65 and (ii) over 75 for each clinical commissioning group (CCG) in England for the each month in the past five years could only be obtained at disproportionate cost.</p><br /><p>We have provided data attached which shows patients with a secondary diagnosis of dementia by CCG of residence for individuals aged (i) over 65 and (ii) over 75, for 2013-14 showing:</p><br /><p>(a) the rates of admission to hospital per age group population,</p><p>(b) the total hospital bed-days per age group population and</p><p>(c) the rates of admission to hospital from a nursing home or residential care home per age group population.</p><br /><p>Please be aware that the 2013-14 data supplied by the Health and Social Care Information Centre (HSCIC) in November 2014 was provisional at the time. HSCIC have since published the 2013-14 data. Further information can found through this link:</p><br /><p><a href="http://www.hscic.gov.uk/article/2021/Website-Search?productid=17192&amp;q=diagnosis+hospital+2013-14&amp;sort=Relevance&amp;size=10&amp;page=1&amp;area=both#top" target="_blank">http://www.hscic.gov.uk/article/2021/Website-Search?productid=17192&amp;q=diagnosis+hospital+2013-14&amp;sort=Relevance&amp;size=10&amp;page=1&amp;area=both#top</a></p><p>Note that some patients who live in nursing homes or residential care may have their source of admission recorded as 'usual place of residence' by the hospital staff but we cannot identify these.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2015 16:57:42 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector.xlsx title Secondary diagnosis of dementia hospital admission
	tabling member	1588 label Biography information for Barbara Keeley

438033

	registered interest
	date	14/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Weather
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when Ministers in his Department were first informed about NHS England's decision to change the data collected in the 2015-16 Winter Daily Situation Reports; when that decision was taken; and who was responsible for making that decision.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	20004
	answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>NHS England worked closely with NHS Trust Development Authority (TDA), Monitor (now NHS Improvement) and the Department over the summer to design the approach to winter monitoring. The approach this year is proportionate and risk based whereby trusts who have previously encountered heightened operational pressure are given the most support and are subject to the closest monitoring locally. Less challenged trusts are subject to a lighter touch approach and are required to submit a smaller selection of data items in the daily return. The overall approach was agreed in September by the respective chief executives of NHS England, TDA and Monitor with the Secretary of State for Health.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2015 13:14:26 answering member 3918 label Biography information for Jane Ellison
	tabling member	1588 label Biography information for Barbara Keeley

522130

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many emergency readmissions within 28 days of discharge there were for patients with a primary or secondary diagnosis of dementia in (a) England and (b) each clinical commissioning group and primary care trust area in each of the last six years.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	38623
	answer	answer is ministerial correction date of answer 06/06/2016 answer text <p>The information is not held in the format requested.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/06/2016 14:17:05 answering member 3918 label Biography information for Jane Ellison
	tabling member	1588 label Biography information for Barbara Keeley

723094

	registered interest
	date	21/04/2017
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	Minimum Wage: Care Homes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask Mr Chancellor of the Exchequer, which social care providers have been identified by HM Revenue and Customs as non-compliant with national minimum wage legislation; how much is owed in arrears by each such provider; to how many staff such arrears are owed; and what value of fines have been levied on care providers to date.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	71600
	answer	answer is ministerial correction date of answer 26/04/2017 answer text <p>HM Revenue and Customs (HMRC) do not comment on individual cases. Anyone who feels they have been underpaid National Minimum Wage or National Living Wage should contact the Acas helpline on 0300 123 1100. HMRC review all complaints that are referred to them.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/04/2017 15:14:42 answering member 3918 label Biography information for Jane Ellison
	tabling member	1588 label Biography information for Barbara Keeley

173713

	registered interest
	date	14/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Meningitis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how the Government's approach to negotiating a cost-effective price for the meningococcal B vaccine Bexsero takes account of fluctuations in disease levels characteristic of that virus and the recent emergence of another strain of meningitis which may be treated using Bexsero.
	tabling member constituency	Workington
	tabling member printed	Sir Tony Cunningham
	uin	220784
	answer	answer is ministerial correction date of answer 20/01/2015 answer text <p>The independent cost-effectiveness analysis of the use of the meningococcal B vaccine, Bexsero took account of the incidence and case fatality rates of all meningococcal disease, including meningococcal W in England during the period 2005-06 to 2011-12. The Joint Committee on Vaccination and Immunisation (JCVI) considered that these data gave a reasonable range. JCVI are the independent experts responsible for advising the Government on immunisations following due consideration of the evidence on the burden of disease, vaccine safety and efficacy and cost effectiveness.</p><p> </p><p> </p><p> </p><p>Further information is available in Christensen H, Trotter CL, Hickman M, Edmunds WJ. Re‑evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ 2014; 349: g5725.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/01/2015 15:36:37 answering member 3918 label Biography information for Jane Ellison
	tabling member	1469 label Biography information for Sir Tony Cunningham

173714

	registered interest
	date	14/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Meningitis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which post in his Department is responsible for leading negotiations on setting a cost-effective price for the meningococcal B vaccine Bexsero; and when the next meeting to continue those negotiations is scheduled.
	tabling member constituency	Workington
	tabling member printed	Sir Tony Cunningham
	uin	220785
	answer	answer is ministerial correction date of answer 20/01/2015 answer text <p>The Department’s Director General for Innovation, Growth and Technology is leading negotiations with the manufacturer for the supply of the meningococcal B vaccine, Bexsero. The most recent negotiating meeting took place on 8 December 2014 and, following subsequent technical discussions, the next such meeting will take place shortly.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/01/2015 14:35:54 answering member 3918 label Biography information for Jane Ellison
	tabling member	1469 label Biography information for Sir Tony Cunningham

225197

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Meningitis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions his Department has had with Novartis during price negotiations on the meningitis B vaccine on risk sharing in the development and implementation of that vaccine.
	tabling member constituency	Workington
	tabling member printed	Sir Tony Cunningham
	uin	226346
	answer	answer is ministerial correction date of answer 11/03/2015 answer text <p>The meningitis B (MenB) vaccine has already been developed by Novartis. Implementation of the MenB programme is dependent on the vaccine being obtained at a cost effective price as recommended by the Joint Committee on Vaccination and Immunisation.</p><p> </p><p> </p><p> </p><p>The Department is continuing to negotiate with the manufacturer and the content of these negotiations is confidential. GlaxoSmithKline (GSK) completed its purchase of Novartis’s non-influenza vaccine business on 2 March 2015 and therefore, further negotiations are continuing with GSK.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/03/2015 16:32:47 answering member 3918 label Biography information for Jane Ellison
	tabling member	1469 label Biography information for Sir Tony Cunningham

416287

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia: Cumbria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the diagnosis rate for dementia of people of each (a) age group and (b) gender in (i) Allerdale borough and (b) Copeland borough has been in each of the last 10 years.
	tabling member constituency	Workington
	tabling member printed	Sue Hayman
	uin	8755
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>Information is not available in the format requested.</p><p> </p><p> </p><p> </p><p>The number of people recorded on the practice dementia disease register is available in the Quality and Outcomes Framework (QOF), published by the Health and Social Care Information Centre, from 2006/07, when dementia indicators were introduced into the framework. The diagnosis rate is not available but the numbers of people on the dementia register are available. This is a measure of prevalence rather than incidence.</p><p> </p><p> </p><p> </p><p>Number of patients on the QOF Dementia Register in Cumbria as at 31 March</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Area</p></td><td><p>Year</p></td><td><p>Number of GP practices</p></td><td><p>Number of patients on the Dementia Register</p></td><td><p>Prevalence (%)</p></td></tr><tr><td><p>NHS Cumbria Clinical Commissioning Group (CCG)</p></td><td><p>2013-14</p></td><td><p>82</p></td><td><p>4,602</p></td><td><p>0.88</p></td></tr><tr><td><p>NHS Cumbria CCG</p></td><td><p>2012-13</p></td><td><p>82</p></td><td><p>4,248</p></td><td><p>0.81</p></td></tr><tr><td><p>Cumbria Teaching Primary Care Trust (PCT)</p></td><td><p>2011-12</p></td><td><p>83</p></td><td><p>3,938</p></td><td><p>0.76</p></td></tr><tr><td><p>Cumbria PCT</p></td><td><p>2010-11</p></td><td><p>90</p></td><td><p>3,524</p></td><td><p>0.68</p></td></tr><tr><td><p>Cumbria PCT</p></td><td><p>2009-10</p></td><td><p>91</p></td><td><p>3,318</p></td><td><p>0.64</p></td></tr><tr><td><p>Cumbria PCT</p></td><td><p>2008-09</p></td><td><p>92</p></td><td><p>3,114</p></td><td><p>0.60</p></td></tr><tr><td><p>Cumbria PCT</p></td><td><p>2007-08</p></td><td><p>93</p></td><td><p>3,008</p></td><td><p>0.58</p></td></tr><tr><td><p>Cumbria PCT</p></td><td><p>2006-07</p></td><td><p>95</p></td><td><p>2,856</p></td><td><p>0.56</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source:</em> Health and Social Care Information Centre</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p>1. Data is received at practice level, however the practice data cannot be used to estimate prevalence for small areas as practices serve registered patients, not defined geographical areas. The QOF data has been provided down to CCG/PCT level.</p><p> </p><p> </p><p> </p><p>2. The figures provided are a snapshot ‘as at 31 March each year’ and are for people of all ages, as a breakdown by age group and gender is not available.</p><p> </p><p> </p><p> </p><p>3. The objective of the QOF is to improve the quality of care that patients are given by rewarding practices for the quality of care they provide to their patients. QOF is therefore an incentive payment scheme. Participation by practices is entirely voluntary, though participation rates are over 95%.</p><p> </p><p> </p><p> </p><p>4. As QOF registers are constructed to underpin indicators on quality of care, they do not necessarily equate to prevalence as may be defined by epidemiologists. For example, prevalence figures based on QOF registers may differ from prevalence from other sources because of coding and definitional issues.</p><p> </p><p> </p><p> </p><p>5. The number of patients on clinical registers can be used to calculate disease prevalence, expressing the number of patients on each register as a percentage of the number of patients on practices’ lists. Therefore, ‘raw prevalence’ for a clinical area is defined as:</p><p> </p><p> </p><p> </p><p>Raw Prevalence = (number on clinical register / number on practice list) *100</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 8771 question first answered 09/09/2015 16:18:49 answering member 3918 label Biography information for Jane Ellison
	tabling member	4395 label Biography information for Baroness Hayman of Ullock